Coffey, S. R., Bragg, R. M., Minnig, S., Ament, S. A., Cantle, J. P., Glickenhaus, A., . . . Carroll, J. B. (2017). Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease. PLoS ONE, 12(4), e0175968. https://doi.org/10.1371/journal.pone.0175968&type=printable
Chicago-referens (17:e uppl.)Coffey, Sydney R., et al. "Peripheral Huntingtin Silencing Does Not Ameliorate Central Signs of Disease in the B6.HttQ111/+ Mouse Model of Huntington's Disease." PLoS ONE 12, no. 4 (2017): e0175968. https://doi.org/10.1371/journal.pone.0175968&type=printable.
MLA-referens (9:e uppl.)Coffey, Sydney R., et al. "Peripheral Huntingtin Silencing Does Not Ameliorate Central Signs of Disease in the B6.HttQ111/+ Mouse Model of Huntington's Disease." PLoS ONE, vol. 12, no. 4, 2017, p. e0175968, https://doi.org/10.1371/journal.pone.0175968&type=printable.